Drug Trial Radar · NCT03982368
A Study to Evaluate Safety and Efficacy of rhNGF Eye Solution vs Vehicle in Patients With Moderate to Severe Dry Eye
Last checked: Nov 20, 2026Latest source record: Apr 19, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
261
Actual
Start
Jun 10, 2019
Primary completion
Jul 15, 2020
Study completion Jul 15, 2020
Sponsor
- Lead sponsor
- Dompé Farmaceutici S.p.AIndustry
- Sponsor type
- Industry
- First posted
- Jun 11, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to assess the efficacy and safety of rhNGF eye drops at 20 μg/ml concentration administered two or three times daily for 4 weeks in patients with moderate to severe dry eye.
Conditions
- Dry Eye Syndrome
Interventions
rhNGF 20 μg/mlDrug
one drop of rhNGF 20 μg/ml will be instilled in both eyes three times daily (every 6-8 hours)
rhNGF 20 μg/ml + vehicleDrug
one drop of rhNGF 20 μg/ml will be instilled in both eyes two times daily plus one drop (40 μL) of vehicle will be instilled in both eyes once daily (every 6-8 hours). rhNGF will be instilled in the morning and in the evening while the vehicle will be instilled in the afternoon.
VehicleOther
one drop of vehicle will be instilled in both eyes three times daily (every 6-8 hours)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Schirmer I Test (Without Anesthesia) vs Week 4 - Full Analysis SetTime frame: Baseline, week 4
- Change From Baseline in Schirmer I Test (Without Anesthesia) vs Week 4 - Per Protocol SetTime frame: Baseline, week 4
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
Global Research Management
Glendale, California
Eye Research Foundation
Newport Beach, California
Martel Eye Medical Group
Rancho Cordova, California
Sierra Clinical Trials & Research Organization
Santa Ana, California
Clayton Eye Clinical Research, LLC
Morrow, Georgia
Kentucky Eye Institute
Lexington, Kentucky
Tauber Eye Center
Kansas City, Missouri
Moyes Eye Center
Kansas City, Missouri
SightMD
Babylon, New York
Toyos Clinic
Nashville, Tennessee
Houston Eye Associates HEA - Gramercy Location
Houston, Texas
Advanced Laser Vision Surgical Institute (Study Site) Intouch Clinical Research Center (SMO)
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.